Apollo Hospitals Enterprise Limited announced plans to set up a 100-bed Comprehensive Oncology Centre at Gurugram integrating the most advanced next generation Proton Therapy System. The centre will be set up as part of the Phase 2 expansion of its upcoming 500-bed hospital in Gurugram. The Phase 1 development at Gurugram is on track to be commissioned by end Fourth Quarter FY25 /First Quarter FY26, while the Proton & Integrated Cancer Centre will follow, with completion targeted over the next four years.
This will be Apollo's third Proton Therapy installation in India, following the success of its flagship Proton Center in Chennai, the first center in South Asia and the Middle East, which has already treated over 2,500 patients from 147 countries, and the second Proton installation underway at Jubilee Hills, Hyderabad, within a dedicated 70-bed comprehensive cancer centre. With Gurugram, Apollo is building a unique pan-India integrated oncology program, reinforcing its pole position in cancer care. The advancements through technology, innovation & expertise is defining Apollo's relentless pursuit of excellence in cancer care.
Proton therapy is an effective treatment primarily for tumors in Paediatric, Head and Neck, Central Nervous System, Bone and soft tissue, Prostate and a wide range of other tumors. According to studies, the global burden of cancer is projected to increase to 21.4 million incident cases by 2030. As per a study published in The Lancet Regional Health, worldwide in terms of absolute incidence number, following China and the US, India ranks third, contributing 7.5% of all new cancer incidences and is expected to grow to 1.5 million this year.
Cancer treatment modalities are undergoing rapid transformation, and Apollo is at the forefront of ushering in next-generation, personalized oncology care. The Gurugram Cancer Centre of the future will bring together: 1. Next generation Proton Therapy - the most advanced radiation technology, delivering precision therapy while sparing healthy tissue. 2. Advanced multi system Robotics - enabling minimally invasive cancer surgeries with enhanced precision.
3. High-End Linear Accelerators for state-of-the-art image-guided and adaptive radiotherapy. 4. Immunotherapy & Targeted Therapies - offering cutting-edge treatment protocols tailored to each patient. 5. Personalized & Genomics-Driven Medicine - transforming outcomes by aligning treatment to the unique biology of every cancer.
6. Bone marrow transplant and Car T cell therapies - a boon to patients with blood disorders and complex malignancies.
